Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase

View ORCID ProfileAlfredo Mari, View ORCID ProfileTim Roloff, View ORCID ProfileMadlen Stange, View ORCID ProfileKirstine K. Søgaard, Erblin Asllanaj, View ORCID ProfileGerardo Tauriello, Leila Tamara Alexander, Michael Schweitzer, View ORCID ProfileKaroline Leuzinger, Alexander Gensch, Aurélien Martinez, View ORCID ProfileJulia Bielicki, Hans Pargger, Martin Siegemund, View ORCID ProfileChristian H. Nickel, Roland Bingisser, View ORCID ProfileMichael Osthoff, View ORCID ProfileStefano Bassetti, View ORCID ProfileParham Sendi, View ORCID ProfileManuel Battegay, View ORCID ProfileCatia Marzolini, View ORCID ProfileHelena M.B. Seth-Smith, View ORCID ProfileTorsten Schwede, View ORCID ProfileHans H. Hirsch, View ORCID ProfileAdrian Egli
doi: https://doi.org/10.1101/2020.12.28.20248663
Alfredo Mari
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
3Swiss Institute of Bioinformatics, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alfredo Mari
Tim Roloff
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
3Swiss Institute of Bioinformatics, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tim Roloff
Madlen Stange
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
3Swiss Institute of Bioinformatics, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Madlen Stange
Kirstine K. Søgaard
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kirstine K. Søgaard
Erblin Asllanaj
3Swiss Institute of Bioinformatics, Basel, Switzerland
4Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerardo Tauriello
3Swiss Institute of Bioinformatics, Basel, Switzerland
4Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerardo Tauriello
Leila Tamara Alexander
3Swiss Institute of Bioinformatics, Basel, Switzerland
4Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schweitzer
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karoline Leuzinger
5Clinical Virology, University Hospital Basel, Basel, Switzerland
6Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karoline Leuzinger
Alexander Gensch
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélien Martinez
7Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Bielicki
8Pediatric Infectious Diseases, Children’s University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Bielicki
Hans Pargger
9Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Siegemund
9Intensive Care Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian H. Nickel
10Emergency Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian H. Nickel
Roland Bingisser
10Emergency Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Osthoff
11Internal Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Osthoff
Stefano Bassetti
11Internal Medicine, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefano Bassetti
Parham Sendi
7Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland
12Institute for Infectious Diseases, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Parham Sendi
Manuel Battegay
7Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel Battegay
Catia Marzolini
7Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catia Marzolini
Helena M.B. Seth-Smith
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
3Swiss Institute of Bioinformatics, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helena M.B. Seth-Smith
Torsten Schwede
3Swiss Institute of Bioinformatics, Basel, Switzerland
4Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Torsten Schwede
Hans H. Hirsch
5Clinical Virology, University Hospital Basel, Basel, Switzerland
6Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland
7Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hans H. Hirsch
Adrian Egli
1Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
2Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian Egli
  • For correspondence: adrian.egli{at}usb.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Antiviral treatments for COVID-19 have involved many repurposed drugs. Currently, SARS-CoV-2 RNA-dependent RNA polymerase (RdRp, encoded by nsp12-nsp7-nsp8) has been targeted by numerous inhibitors with debated clinical impact. Among these, remdesivir has been conditionally approved for the treatment of COVID-19 patients. Although the emergence of antiviral resistance, an indirect proxy for antiviral efficacy, poses a considerable healthcare threat, an evolutionary perspective on emerging resistant mutants is still lacking.

Here we show that SARS-CoV-2 RdRp is under purifying selection, that potential escape mutations are rare, and unlikely to lead to viral fitness loss.

In more than 56,000 viral genomes from 105 countries dating from December 2019 to July 2020 we found negative selective pressure affecting nsp12 (Tajima’s D = −2.62), with potential antiviral escape mutations in only 0.3% of sequenced genomes. Those affected known key residues, such as Nsp12:Val473 and Nsp12:Arg555. Of the potential escape mutations found globally, in silico structural models show that this rarely implies loss of stability in RdRp. No potential escape mutation were found in our local cohort of remdesivir treated patients from the first wave (n=8). Our results indicate that RdRp is a suitable drug target, and that remdesivir does not seem to exert high selective pressure. Our study could be the starting point of a larger monitoring effort of drug resistance throughout the COVID-19 pandemic. We recommend the application of repetitive genome sequencing of SARS-CoV-2 from patients treated with antivirals to provide early insights into the evolution or antiviral resistance.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04323761, NCT04351503

Funding Statement

No dedicated funding was received for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted according to good laboratory practice and in accordance with the Declaration of Helsinki and national and institutional standards and was approved by the ethical committee (EKNZ: Ethikkommission Nordwest- und Zentralschweiz, Hebelstrasse 53, 4056 Basel, https://www.eknz.ch/) (Authorisation EKNZ 2020-00769). The clinical trial accession numbers are NCT04323761 and NCT04351503 (clinicaltrials.gov).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Genome assemblies from the Basel open cohort were submitted to GISAID. Amplicon sequences from the remdesivir treated patients are available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase
Alfredo Mari, Tim Roloff, Madlen Stange, Kirstine K. Søgaard, Erblin Asllanaj, Gerardo Tauriello, Leila Tamara Alexander, Michael Schweitzer, Karoline Leuzinger, Alexander Gensch, Aurélien Martinez, Julia Bielicki, Hans Pargger, Martin Siegemund, Christian H. Nickel, Roland Bingisser, Michael Osthoff, Stefano Bassetti, Parham Sendi, Manuel Battegay, Catia Marzolini, Helena M.B. Seth-Smith, Torsten Schwede, Hans H. Hirsch, Adrian Egli
medRxiv 2020.12.28.20248663; doi: https://doi.org/10.1101/2020.12.28.20248663
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase
Alfredo Mari, Tim Roloff, Madlen Stange, Kirstine K. Søgaard, Erblin Asllanaj, Gerardo Tauriello, Leila Tamara Alexander, Michael Schweitzer, Karoline Leuzinger, Alexander Gensch, Aurélien Martinez, Julia Bielicki, Hans Pargger, Martin Siegemund, Christian H. Nickel, Roland Bingisser, Michael Osthoff, Stefano Bassetti, Parham Sendi, Manuel Battegay, Catia Marzolini, Helena M.B. Seth-Smith, Torsten Schwede, Hans H. Hirsch, Adrian Egli
medRxiv 2020.12.28.20248663; doi: https://doi.org/10.1101/2020.12.28.20248663

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3297)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (432)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (524)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7507)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)